Shenzhen Weiguang Biological Products Co., Ltd.
SZSE:002880.SZ
33.35 (CNY) • At close October 26, 2023
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Omzet
| 1,048.503 | 667.931 | 907.435 | 904.565 | 821.469 | 687.949 | 623.39 | 566.137 | 500.944 | 452.773 | 355.21 | 300.066 |
Kosten van de omzet
| 615.259 | 427.024 | 536.523 | 568.218 | 506.133 | 414.328 | 347.175 | 297.838 | 268.009 | 252.028 | 179.89 | 154.997 |
Brutowinst
| 433.244 | 240.907 | 370.912 | 336.346 | 315.336 | 273.622 | 276.215 | 268.298 | 232.936 | 200.745 | 175.32 | 145.07 |
Brutowinstmarge
| 0.413 | 0.361 | 0.409 | 0.372 | 0.384 | 0.398 | 0.443 | 0.474 | 0.465 | 0.443 | 0.494 | 0.483 |
Onderzoek- en ontwikkelingskosten
| 63.616 | 35.866 | 47.586 | 45.097 | 40.165 | 23.702 | 25.626 | 24.774 | 19.779 | 13.779 | 15.469 | 11.936 |
Algemene en administratieve kosten
| 24.682 | 18.017 | 21.17 | 27.998 | 24.697 | 18.054 | 18.716 | 17.106 | 13.985 | 12.106 | 47.305 | 42.988 |
Verkoop- en marketingkosten
| 40.885 | 27.254 | 23.785 | 19.691 | 24.019 | 24.012 | 14.353 | 12.845 | 12.16 | 11.303 | 11.922 | 11.405 |
Verkoop-, algemene en administratieve kosten
| 65.566 | 45.272 | 44.955 | 47.689 | 48.716 | 42.066 | 33.069 | 29.951 | 26.145 | 23.408 | 59.227 | 54.393 |
Overige kosten
| -1.854 | 42.6 | 41.33 | 31.548 | 24.443 | 1.35 | 10.501 | 28.335 | 31.102 | 31.39 | 11.004 | 4.448 |
Bedrijfskosten
| 184.102 | 123.738 | 133.87 | 124.333 | 113.324 | 88.038 | 83.717 | 82.33 | 69.611 | 59.082 | 62.508 | 58.543 |
Bedrijfsresultaat
| 247.309 | 138.167 | 241.741 | 220.645 | 199.144 | 182 | 178.838 | 168.557 | 139.09 | 111.11 | 93.17 | 79.167 |
Bedrijfsresultaat ratio
| 0.236 | 0.207 | 0.266 | 0.244 | 0.242 | 0.265 | 0.287 | 0.298 | 0.278 | 0.245 | 0.262 | 0.264 |
Totaal overige inkomsten en kosten netto
| -1.854 | -0.85 | -0.566 | -1.604 | -0.85 | -3.761 | -11.714 | -6.492 | -17.679 | -23.817 | -8.639 | -3.32 |
Inkomen voor belasting
| 245.455 | 137.317 | 241.174 | 219.041 | 198.293 | 181.823 | 180.784 | 179.477 | 145.645 | 117.847 | 104.174 | 83.206 |
Inkomen voor belasting ratio
| 0.234 | 0.206 | 0.266 | 0.242 | 0.241 | 0.264 | 0.29 | 0.317 | 0.291 | 0.26 | 0.293 | 0.277 |
Belastingkosten
| 27.91 | 16.197 | 36.182 | 29.456 | 27.142 | 25.186 | 26.035 | 26.25 | 20.79 | 17.305 | 15.293 | 11.76 |
Nettowinst
| 218.651 | 117.518 | 205.437 | 190.399 | 171.345 | 156.637 | 154.749 | 153.227 | 124.855 | 100.542 | 88.881 | 71.445 |
Nettowinstmarge
| 0.209 | 0.176 | 0.226 | 0.21 | 0.209 | 0.228 | 0.248 | 0.271 | 0.249 | 0.222 | 0.25 | 0.238 |
WPA (Winst Per Aandeel)
| 0.96 | 0.52 | 0.91 | 0.84 | 0.76 | 0.69 | 0.78 | 0.9 | 0.73 | 0.59 | 0.52 | 0.42 |
Verwaterde WPA
| 0.96 | 0.52 | 0.91 | 0.84 | 0.76 | 0.69 | 0.78 | 0.9 | 0.73 | 0.59 | 0.52 | 0.42 |
EBITDA
| 341.646 | 189.464 | 300.58 | 264.367 | 242.332 | 229.456 | 240.37 | 237.737 | 210.898 | 187.998 | 142.609 | 102.52 |
EBITDA ratio
| 0.326 | 0.284 | 0.331 | 0.292 | 0.295 | 0.334 | 0.386 | 0.42 | 0.421 | 0.415 | 0.401 | 0.342 |